Doctors shouldn't practice unethical, unscientific Covid treatment: Dr Kang

Kang is a top virologist

Gagandeep Kang
Dr Gagandeep Kang | File photo
ANI General News
3 min read Last Updated : Jan 24 2022 | 6:38 AM IST

India's top virologist, Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific" and asked the medical fraternity to "practice better medicine than this".

Notably, monoclonal antibodies treatment for COVID has been excluded in the revised National COVID task force treatment.

In a series of tweets, Dr Kang said that she received a call from a 90-year-old diabetic patient from Chennai who narrated to her that he was advised admission to the hospital for the antibody treatment because he was in contact with someone who tested positive for SARS-CoV2.

"A call from a 90-year diabetic uncle in Chennai who said he has advised admission to hospital and antibody treatment because he was in contact with someone who tested positive for SARS-CoV2 sparked this thread," she Dr Kang tweeted.

"We know that 90 per cent or greater infections are currently Omicron in Indian cities. We know that the licensed monoclonal antibody products in India do not neutralise omicron. Yet doctors in private hospitals are prescribing monoclonal antibody therapy (and admission)," she added in her tweet.

The Doctor further pointed out that there is little data in India which is why we do not know if the percentage of vaccinated elderly with Omicron will progress.

"Please remember that even among clinical vulnerable, most contacts will stay asymptomatic or have mild symptoms & recover. Small no. develop severe illness (in India, we have little data so we do not know whether 5% or 20% of vaccinated elderly with omicron will progress)," she tweeted.

"In any case, all the ones who would have gotten better anyway will do fine--but having given antibodies, doctors will ascribe that to their treatment and the hospitals will laugh all the way to the bank. The argument I hear from well-meaning doctors (thankfully not infectious disease specialists) is that it is only one lakh and my patient can afford to buy it, so why not?" Dr Kang said in the tweet.

Dr Kang said that it is unethical, immoral and unscientific to provide the antibodies treatment and asked the doctors to practise better medicine.

"Why not? It is unethical, immoral and unscientific. Surely, as doctors, we can teach and practice better medicine than this. And as patients, please ask for what each drug is expected to do and the evidence to back that up," Dr Kang said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusGagandeep Kang

First Published: Jan 24 2022 | 6:38 AM IST

Next Story